Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1049876 | 0.86 | — | — | |
| SCHEMBL1048345 | 0.82 | — | — | |
| SCHEMBL338177 | 0.80 | GABRA1 (0.38) | TRPA1ALDH1A1TSHR | |
| SCHEMBL10933403 | 0.78 | — | — | |
| SCHEMBL1525361 | 0.76 | — | — | |
| SCHEMBL3310091 | 0.76 | GPR84 (0.31) | — | |
| SCHEMBL11427181 | 0.76 | PNMT (0.33) | — | |
| SCHEMBL7777200 | 0.74 | TRPA1 (0.35) | TRPA1ALDH1A1TSHR | |
| SCHEMBL4158272 | 0.74 | TRPA1 (0.35) | TRPA1ALDH1A1TSHR | |
| SCHEMBL4158266 | 0.74 | TRPA1 (0.35) | TRPA1ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 254 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11524989-B2 | AML antigens and uses thereof | KLING BIOTHERAPEUTICS B.V. (NL) | 2022-12-13 | — | — | US | claimed |
| EP-3060915-A2 | DETECTION OF CLEAVAGE ACTIVITY OF AN ENZYME | Mologic Limited (GB) | 2016-08-31 | — | — | EP | claimed |
| US-9176127-B2 | Method for selecting a candidate drug compound | PEPSCAN SYSTEMS B.V. (NL) | 2015-11-03 | — | — | US | claimed |
| WO-2015059487-A2 | DETECTION OF CLEAVAGE ACTIVITY OF AN ENZYME | MOLOGIC LIMITED (GB) | 2015-04-30 | — | — | WO | claimed |
| US-20140308303-A1 | METHOD FOR SELECTING A CANDIDATE DRUG COMPOUND | PEPSCAN SYSTEMS B.V. (NL) | 2014-10-16 | — | — | US | claimed |
| US-8748105-B2 | Method for selecting a candidate drug compound | PEPSCAN SYSTEMS B.V. (NL) | 2014-06-10 | — | — | US | claimed |
| EP-1597585-B1 | METHOD FOR SELECTING A CANDIDATE DRUG COMPOUND | PEPSCAN SYSTEMS BV (NL) | 2011-06-15 | — | — | EP | claimed |
| US-20100322945-A1 | IMMUNOGENIC COMPOUNDS AND PROTEIN MIMICS | PEPSCAN SYSTEMS B.V. (NL) | 2010-12-23 | — | — | US | claimed |
| EP-2052253-A2 | IMMUNOGENIC COMPOUNDS AND PROTEIN MIMICS | PEPSCAN SYSTEMS B.V. (NL) | 2009-04-29 | — | — | EP | claimed |
| US-20080313749-A1 | Binding Compounds, Immunogenic Compounds and Peptidomimetics | PEPSCAN SYSTEMS B.V. (NL) | 2008-12-18 | — | — | US | claimed |
| WO-2008013454-A2 | IMMUNOGENIC COMPOUNDS AND PROTEIN MIMICS | PEPSCAN SYSTEMS B.V. (NL) | 2008-01-31 | — | — | WO | claimed |
| EP-1844337-A1 | BINDING COMPOUNDS, IMMUNOGENIC COMPOUNDS AND PEPTIDOMIMETICS | PEPSCAN SYSTEMS B.V. (NL) | 2007-10-17 | — | — | EP | claimed |
| WO-2006078161-A1 | BINDING COMPOUNDS, IMMUNOGENIC COMPOUNDS AND PEPTIDOMIMETICS | PEPSCAN SYSTEMS B.V. (NL) | 2006-07-27 | — | — | WO | claimed |
| US-20060073518-A1 | Method for selecting a candidate drug compound | PEPSCAN SYSTEMS B. V. (NL) | 2006-04-06 | — | — | US | claimed |
| EP-1597585-A2 | METHOD FOR SELECTING A CANDIDATE DRUG COMPOUND | PEPSCAN SYSTEMS B.V. (NL) | 2005-11-23 | — | — | EP | claimed |
| WO-2004077062-A2 | METHOD FOR SELECTING A CANDIDATE DRUG COMPOUND | PEPSCAN SYSTEMS B.V. (NL) | 2004-09-10 | — | — | WO | claimed |
| EP-1452868-A2 | Method for selecting a candidate drug compound | PEPSCAN SYSTEMS B.V. (NL) | 2004-09-01 | — | — | EP | claimed |
| US-20260137791-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR PD-L1 | Bicyclerd Limited (GB) | 2026-05-21 | — | — | US | disclosed |
| US-4351924-A | USING A REACTION PRODUCT OF AN ORGANO ALKALI METAL ACETAL OR KETAL AND 1,1-DIPHENYLETHYLENE; AUTOMOBILE POWDER COATINGS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-09-28 | — | — | US | disclosed |
| US-3959232-A | Polyamide from hexahydrobenzodipyrrole | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1976-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080313749-A1 | Binding Compounds, Immunogenic Compounds and Peptidomimetics | CXCL10, CCL2, CD74 | TRPA1 174/4885ALDH1A1 4812/4885TSHR 3066/4885 |
| US-20260137791-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR PD-L1 | PDCD1LG2, CD274, PDCD1 | TRPA1 4657/4885ALDH1A1 3312/4885TSHR 931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.